Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Hinchey presses FDA

This article was originally published in The Tan Sheet

Executive Summary

Rep. Maurice Hinchey (D-N.Y.) will use an upcoming hearing on FDA's budget request to pose questions about conflicts of interest to Acting Commissioner Andrew von Eschenbach, Hinchey's office says. Von Eschenbach is scheduled to discuss FDA's budget request for fiscal 2007 at a Feb. 16 hearing held by the Appropriations Subcommittee on Agriculture, Rural Development, FDA & Related Agencies. Hinchey says his questions will center on "von Eschenbach's own conflict as NCI Director," FDA's recently restated policy of preemption and the agency's "cozy relationship" with the drug industry. The congressman has campaigned to prevent scientists and doctors with conflicts of interest from participating on FDA committees. In September, he requested that the HHS Office of the Inspector General review the resignation of former FDA Commissioner Lester Crawford (1"The Tan Sheet" Oct. 31, 2005, In Brief)...

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS099094

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel